Overexpression of SENP3 in oral squamous cell carcinoma and its association with differentiation

Oncology Reports

Volumn 29, Issue 5, 2013, Pages 1701-1706

  Sun, Zujun ^a   Hu, Shuiqing ^a   Luo, Qingqiong ^a   Ye, Dongxia ^a   Hu, Dan ^a   Chen, Fuxiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Oral squamous cell carcinoma; Reactive oxygen species; Small ubiquitin like modifier; Small ubiquitin like modifier specific proteases

Indexed keywords

REACTIVE OXYGEN METABOLITE; SUMO 3 PROTEIN;

ARTICLE; CANCER GRADING; CANCER PATIENT; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUTH SQUAMOUS CELL CARCINOMA; NUCLEOLUS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; TISSUE DIFFERENTIATION; TUMOR DIFFERENTIATION;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL NUCLEUS; CYSTEINE ENDOPEPTIDASES; FEMALE; HUMANS; MALE; MOUTH MUCOSA; MOUTH NEOPLASMS; REACTIVE OXYGEN SPECIES; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS;

EID: 84876280247     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2318     Document Type: Article

References (31)

1. Kademani D: Oral cancer. Mayo Clin Proc 82: 878-887, 2007.
2. Petersen PE: The World Oral Health Report 2003: continuous improvement of oral health in the 21st century - the approach of WHO Global Programme. Commun Dent Oral Epidemiol 31 (Suppl 1): 3-23, 2003.
3. Neville BW and Day TA: Oral cancer and precancerous lesions. CA Cancer J Clin 52: 195-215, 2002.
4. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
5. Hay RT: SUMO: a history of modification. Mol Cell 18: 1-12, 2005.
6. Yeh ET, Gong L and Kamitani T: Ubiquitin-like proteins: new wines in new bottles. Gene 248: 1-14, 2000. (Pubitemid 30259196)
7. Cheng J, Kang X, Zhang S and Yeh ET: SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 131: 584-595, 2007. (Pubitemid 350007694)
8. Cheng J, Perkins ND and Yeh ET: Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases. J Biol Chem 280: 14492-14498, 2005. (Pubitemid 40562790)
9. Cheng J, Wang D, Wang Z and Yeh ET: SENP1 enhan ces androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol 24: 6021-6028, 2004. (Pubitemid 38787984)
10. Degerny C, Monte D, Beaudoin C, Jaffray E, Portois L, Hay RT, de Launoit Y and Baert JL: SUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activity. J Biol Chem 280: 24330-24338, 2005. (Pubitemid 40934515)
11. Di Bacco A, Ouyang J, Lee HY, Catic A, Ploegh H and Gil G: The SUMO-specific protease SENP5 is required for cell division. Mol Cell Biol 26: 4489-4498, 2006. (Pubitemid 43877569)
12. Haindl M, Harasim T, Eick D and Muller S: The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing. EMBO Rep 9: 273-279, 2008. (Pubitemid 351330993)
13. Cheng J, Bawa T, Lee P, Gong L and Yeh ET: Role of desumoylation in the development of prostate cancer. Neoplasia 8: 667-676, 2006. (Pubitemid 44379793)
14. Gong L and Yeh ET: Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J Biol Chem 281: 15869-15877, 2006. (Pubitemid 43848478)
15. Huang C, Han Y, Wang Y, Sun X, Yan S, Yeh ET, Chen Y, et al: SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO J 28: 2748-2762, 2009.
16. Han Y, Huang C, Sun X, Xiang B, Wang M, Yeh ET, Chen Y, et al: SENP3-mediated de-conjugation of SUMO2/3 from promytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress. J Biol Chem 285: 12906-12915, 2010.
17. Saitoh H and Hinchey J: Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem 275: 6252-6258, 2000. (Pubitemid 30129915)
18. Manza LL, Codreanu SG, Stamer SL, Smith DL, Wells KS, Roberts RL and Liebler DC: Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem Res Toxicol 17: 1706-1715, 2004. (Pubitemid 39665564)
19. Li T, Santockyte R, Shen RF, Tekle E, Wang G, Yang DC and Chock PB: Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways. J Biol Chem 281: 36221-36227, 2006. (Pubitemid 46041356)
20. Dorval V and Fraser PE: SUMO on the road to neurodegeneration. Biochim Biophys Acta 1773: 694-706, 2007. (Pubitemid 46830946)
21. Cimarosti H, Lindberg C, Bomholt SF, Ronn LC and Henley JM: Increased protein SUMOylation following focal cerebral ischemia. Neuropharmacology 54: 280-289, 2008.
22. Yang W, Sheng H, Warner DS and Paschen W: Transient global cerebral ischemia induces a massive increase in protein sumoylation. J Cereb Blood Flow Metab 28: 269-279, 2008. (Pubitemid 351161280)
23. Zhang X and Reichart PA: A review of betel quid chewing, oral cancer and precancer in mainland China. Oral Oncol 43: 424-430, 2007. (Pubitemid 46578312)
24. Richie JP, Kleinman W, Marina P, Abraham P, Wynder EL and Muscat JE: Blood iron, glutathione, and micronutrient levels and the risk of oral cancer. Nutr Cancer 60: 474-482, 2008.
25. Barnes L, Eveson JW, Reichart P and Sidransky D (eds): World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. IARC Press, Lyon, pp168-175, 2005.
26. Jacques C, Baris O, Prunier-Mirebeau D, Savaqner F, Rodien P, Rohmer V, Franc B, et al: Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors. J Clin Endocrinol Metab 90: 2314-2320, 2005. (Pubitemid 40586279)
27. Zunino R, Schauss A, Rippstein P, Andrade-Navarro M and McBride HM: The SUMO protease SENP5 is required to maintain mitochondrial morphology and function. J Cell Sci 120: 1178-1188, 2007. (Pubitemid 46711836)
28. Ding X, Sun J, Wang L, Li G, Shen Y, Zhou X and Chen W: Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation. Oncol Rep 20: 1041-1045, 2008.
29. Nishida T, Tanaka H and Yasuda H: A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur J Biochem 267: 6423-6427, 2000.
30. Yan S, Sun X, Xiang B, Cang H, Kang X, Chen Y, Li H, et al: Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90. EMBO J 29: 3773-3786, 2010.
31. Xu Z, Lam LS, Lam LH, Chau SF, Ng TB and Au SW: Molecular basis of the redox regulation of SUMO proteases: a protective mechanism of intermolecular disulfide linkage against irreversible sulfhydryl oxidation. FASEB J 22: 127-137, 2008.